Sympazan

Active Ingredient(s): Clobazam
FDA Approved: * November 1, 2018
Pharm Company: * AQUESTIVE THERAPEUTICS
Category: Anticonvulsant

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Sympazan Overview

Clobazam (marketed under the brand names Frisium, Urbanol, Onfi, and Tapclob ) is a benzodiazepine class medication that was patented in 1968[1] and has been marketed as an anxiolytic since 1975[2] and an anticonvulsant since 1984.[3] Contents 1 Medical uses 2 Contraindications 3 Side effects 3.1 Common 3.2 Post Marketing Experience 3.3 Warnings and Precautions 3.4 Drug interactions 3.5 Overdose 3.6 Abuse potential and addiction 3.7 Depende...

Read more Sympazan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Clobazam

Recent Sympazan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Sympazan: (3 results)

Sorted by National Drug Code

• 10094-205 Sympazan 5 mg Oral Film by Aquestive Therapeutics
• 10094-210 Sympazan 10 mg Oral Film by Aquestive Therapeutics
• 10094-220 Sympazan 20 mg Oral Film by Aquestive Therapeutics

Other drugs which contain Clobazam or a similar ingredient: (3 results)

• CLOBAZAM 33 discussions
• FRISIUM Clobazam28 discussions
• ONFI Clobazam1 discussion